JPRN-jRCTs051210170
Recruiting
未知
Bolus Administration of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy after Emergency Percutaneous Coronary Intervention. - Bolus-pCINC Study
Watanabe Makoto0 sites260 target enrollmentFebruary 7, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Acute myocardial inferction (ST-elevation myocardial infarction, non-ST-segment elevation myocard)
- Sponsor
- Watanabe Makoto
- Enrollment
- 260
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 20 years old and over
- •2 Patients heading directly to the cardiac catheterization laboratory from the emergency outpatient department or patients with in\-hospital onset
- •3 Patients with suspected acute myocardial infarction based on changes in electrocardiogram, elevation of myocardial enzyme, or echocardiography
- •4 Patients who consented to patient or legal acceptable representative in the study
Exclusion Criteria
- •1 Patients with shock or cardiopulmonary arrest upon arrival at the emergency department
- •2 Patients with impaired consciousness, orthopnoea, or needing tracheal intubation and non\-invasive positive pressure ventilation (NIPPV) upon arrival at emergency department
- •3 Patients who received oral or intravenous sodium bicarbonate before CAG was performed
- •4 Patients who are allergic to contrast agents at the time of registration
- •5 Patients who undergoing dialysis
- •6 Patients who uncontrolled hyperthyroidism or hypothyroidism
- •7 Patients who received contrast media within 7 days of CAG or PCI
- •8 Patients who did not undergo PCI as the result of CAG
- •9 Patients who did not diagnosed with acute myocardial infarction
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 2
Sodium Bicarbonate Infusion at Low Concentration to Reduce Kidney Insufficiency by Angiographic Non-iodinated Contrast MediaContrast-Induced NephropathyJPRN-C000000419Department of Cardiovascular Medicine, Kyoto University Hospital500
Completed
Phase 3
Effect of Oral Sodium Bicarbonate Supplementation on urine TGF-beta in normal serum bicarbonate CKD, A randomized control trial.on-diabetic chronic kidney disease with subclinical metabolic acidosisBicarbonate, urine TGF-beta, urine ammonium, chronic kidney diseaseTCTR20240817007Department of Medicine, Phramongkutklao Hospital and College of Medicine64
Active, not recruiting
Not Applicable
Sodium Bicarbonate for the prevention of Contrast Induced Nephropathy in patients undergoing CTPA - The Nephros StudyThe prevention of Contrast Induced Nephropathy is under investigation.Contrast induced nephropathy (CIN) can occur after injecting radiographic iso osmolair contrast media. Patients with a renal impairment or a decreased renal function and aspecially in combination with diabetis mellitus are at risk for developing CIN.MedDRA version: 12.0Level: LLTClassification code 10037790Term: Radiocontrast nephropathyEUCTR2009-013547-11-NLeids Universitair Medisch Centrum
Completed
Phase 4
Sodium Bicarbonate for kidney protection in patients undergoing liver transplantatioiver transplantationAcute Kidney InjuryLiver transplantationAnaesthesiology - AnaestheticsSurgery - Other surgeryRenal and Urogenital - Other renal and urogenital disordersACTRN12611001290987Austin Hospital60
Active, not recruiting
Not Applicable
Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy in Diabetic Patients with Renal InsufficiencyDiabetes mellitus with renal insufficiencyMedDRA version: 9.1Level: LLTClassification code 10012601Term: Diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiencyEUCTR2007-007546-36-CZInstitute for Clinical and Experimental Medicine